Provider review

Peter MD review

A wide multi-category clinic, but no confirmed microdose SKU.

Its published tirzepatide dose is in the standard maintenance range, and neither GLP-1 line is sold as its own low-dose product.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.

$149/mo GLP1+B12 · $249/mo tirz (quarterly)

Visit Peter MD

Price as published

Peter MD

$149/mo GLP1+B12 · $249/mo tirz (quarterly)

Vs median: $20/mo below the $169 median
Market: $59–$1,300/mo across 261 of 407
Structure: Standard plan, self-directed low dose
Dispensed: Pharmacy not publicly identified

Visit Peter MD

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

On this page (9)

The verdict
Who it suits, and who it does not
What it actually costs
What is included
Pharmacy, labs and oversight
How the program works
The honest cons
How it compares
Read this before you buy

In one paragraph

The verdict

Peter MD's case is breadth, not a low-dose product: TRT, GLP-1, NAD+, sermorelin, men's hair loss and ED all live under one physician-prescribed account, and every price is published openly on its own site rather than gated behind a quiz. What it does not have, as far as its own product pages show, is a dedicated microdose SKU — the tirzepatide plan states a 60mg dose, which sits in the standard maintenance range rather than a starting-low tier, and the GLP1 + B12 semaglutide plan is priced by first-time-vs-returning status rather than by dose size. For a reader here specifically to start low, that is a real gap worth naming plainly rather than talking around.

Visit Peter MD

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

You want TRT, GLP-1, NAD+, sermorelin and hair-loss care managed through one account rather than several separate telehealth logins
You want to see a price on the provider's own page before starting an intake
You are comfortable self-directing a lower dose inside a standard plan rather than buying a purpose-built microdose product

Look elsewhere if

You specifically want a named, separately priced microdose tier — none is confirmed here
You want one all-in monthly figure rather than tiers that shift with first-time-vs-returning status or billing cadence
You need your state's exact treatment-by-treatment restrictions confirmed up front — the public pages show a shorter excluded-state list than the affiliate program's own data does

What it actually costs

Price as published

$149/mo GLP1+B12 · $249/mo tirz (quarterly)

Vs median: $20/mo below the $169 median across the 261 of 407 programs here that publish a plain monthly rate
Market: $59–$1,300/mo is the full published spread on this site
Structure: Standard plan, self-directed low dose

No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.

159 of the 407 programs here price a small dose this way. Its tirzepatide plan is a 60 mg maintenance-range dose, not a microdose, and neither GLP-1 line is sold as a separately priced low-dose product — so starting low means asking for less inside a standard plan.

See Peter MD's current price

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult: Included in the price
Dietitian: Not included
Labs: Optional
Pricing: Varies by dose, plan or tier

What it does well

Broad product line under one account — TRT, GLP-1, NAD+, Sermorelin, men's hair loss and ED — so multiple protocols can be managed through a single telehealth relationship
Physician-prescribed, nationwide telehealth brand with a real operating history (founded 2021, HQ Miami, FL)
Pricing for every line above is published openly on the provider's own product pages, no quiz required to see a figure

Start with Peter MD

Pharmacy, labs and oversight

Peter MD does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.

Transparency check

2 of 4 published openly

What Peter MD publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.: Not published
A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.: Published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.: Not published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.: None on file

How the program works

Peter MD is a physician-prescribed telehealth brand founded in 2021 and headquartered in Miami, FL, selling across TRT, ED, non-GLP-1 weight loss, GLP-1, men's hair loss and NAD+ from a single account. Its GLP-1 line is compounded semaglutide sold as "GLP1 + B12" (Level 1 for first-time users at $149/mo, Level 2 for returning users at $139/mo) and tirzepatide at $149 for the first month then $249/mo billed quarterly at a 60mg dose. That 60mg figure sits in the standard maintenance range rather than a microdose, and neither GLP-1 line is presented on its own product pages as a separately priced low-dose SKU — so there is no confirmed microdose tier to point to here, unlike the handful of rows here that do sell one as its own product. The broader catalog is genuinely wide: Sermorelin, injectable NAD+, and TRT (testosterone cypionate) round out a longevity-and-hormone lineup most single-purpose GLP-1 clinics do not carry. The customer-facing pages state a short excluded-state list per product (e.g., AL/ID on tirzepatide, plus AK/HI on semaglutide), but Peter MD's own affiliate-program disclosures list a longer, treatment-by-treatment set of exclusions — AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC and TX appear somewhere across B-12, tirzepatide, HCG, semaglutide, phentermine, TRT injectables and enclomiphene — so restrictions vary by treatment and are not fully disclosed in one place on the marketing site.

See how Peter MD works

The honest cons

No confirmed low-dose or microdose SKU — the tirzepatide plan is a 60mg maintenance-range dose, not a microdose, and the GLP1 + B12 semaglutide tiers are standard plans, not a dedicated start-low product, which is a real fit gap for a reader here specifically to microdose

Price varies by tier and by first-time vs. returning-user status, and the GLP1 + B12 branding means it is not marketed under the generic "semaglutide" name
State restrictions vary by treatment and are not fully disclosed on the public marketing pages — the affiliate program's own data lists a longer excluded-state set (AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC, TX across different products) than the customer-facing pages show
Customer reviews are mixed

Visit Peter MD

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

Peter MD is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Where this sits

#18 of 407

Ordered with the companies that pay us first, and Peter MD is one of them. A disclosed partition, not a score.

Compare all 407 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Start with Peter MD

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

RxSpan MD

$249/mo month to month ($199 on 6-mo)

Vs median: $80/mo above the $169 median
Market: $59–$1,300/mo across 261 of 407
Structure: Standard plan, self-directed low dose
Dispensed: Pharmacy not publicly identified

Visit RxSpan MD

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the RxSpan MD review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.